DRMA Competitors & Alternatives
Compare Dermata Therapeutics Inc with similar stocks in the same industry
Biotechnology
DRMA
Main Stock$1.35
Tradestie Score
52
Market Cap
$3.50M
Analyst Upside
+196.3%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.21
|
$133.50M | - | 66 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.43
|
$114.01M | - | 61 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$28.03
|
$110.20M | - | 63 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.45
|
$71.69M | - | 54 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.52
|
$67.94M | - | 61 | Compare |
|
PALI
Palisade Bio, Inc. Common Stock
|
$1.89
|
$12.21M | 16.3 | 52 | Compare |
|
RNAZ
TransCode Therapeutics, Inc. Common Stock
|
$8.56
|
$8.85M | - | 56 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.28
|
$7.21M | - | 51 | Compare |
|
BBLG
Bone Biologics Corp Common Stock
|
$1.30
|
$5.01M | - | 51 | Compare |
|
REVB
Revelation Biosciences, Inc. Common Stock
|
$0.99
|
$3.42M | - | 43 | Compare |
More DRMA Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry